Medikra INC F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
MDKR
Medikra INCMedikra Inc., a clinical-stage biopharmaceutical company, filed an F-1/A for its initial public offering of 4,545,455 ordinary shares, aiming for a Nasdaq listing.